Company Profile

Legend Biotech Corporation (NASDAQ: LEGN)
8:00 PM UTC, 09/27/24
Last: $49.27 Change: +2.42 %Change: +5.17% Volume: 984,055
Detailed Quote
Open: $ 47.32   Volume: 984,055
High: $ 49.87   Yield(%) 0.00
Low: $ 47.00   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 8.58B
EPS ($) -1.57   Shares Out: 183.17M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -17.39
% Price Change (last 13 weeks): 4.90
% Price Change (last 26 weeks): -16.47
% Price Change (last 52 weeks): -30.40
% Price Change (year to date): -22.14
Management Effectiveness
Return on Equity (%): -51.94
Return on Assets (%): -32.60
Return on Invested Capital (%): -131.18
Profitability
Gross Profit Margin (%): 42.25
Net Profit Margin (%): -181.75
Operating Profit Margin (%): -155.09
Price & Volume
50-day Moving Average: $54.20
200-day Moving Average: $53.66
Avg. Daily Vol. (last 50 days): 815,913
Avg. Daily Vol. (last 200 days): 1,012,969
52-wk high: $70.78
52-wk low: $38.60
Bid: $49.00
Ask: $50.00
Company Information
Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.
Legend Biotech Corporation
2101 Cottontail Lane
Somerset NJ 08873

Phone: 1.737.317.5050
Fax: n/a
http://www.legendbiotech.com
Per Share Data
Earnings (1year) ($): -1.57
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 6.88
Cash Flow ($): -2.74
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 37.16
Price/Book (x): 8.75
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 6.83
Current Ratio (x): 6.92
LT Debt/Equity (x): 26.01
Total Debt/Equity (x): 26.26



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2021 Wall Street Horizon, Inc.